Dazodalibep not checked

Amgen · VIB4920 · MEDI4920

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
2 active
8 in total · 3 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Sjögren's Syndrome (SS), Sjögren's Syndrome
Main trialPhase 3
“Primary Objective: To evaluate the effect of dazodalibep on patient-reported symptoms of SS in participants with moderate-to-severe symptom state Secondary Objectives: 1. To evaluate the effect of dazodalibep on patient-reported outcomes (PROs) in participants with SS. 2. To evaluate the effect of dazodalibep on measures of systemic activity, PROs, and salivary flow in participants with SS 3. To evaluate the safety and tolerability of multiple doses of dazodalibep in participants with SS”In the company’s words, NCT06245408 on ClinicalTrials.gov
Other names
VIB4920 · MEDI4920 · AMG 611

Other drugs for Sjögren's Syndrome (SS)

All 21 drugs for Sjögren's Syndrome (SS)

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials8

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 22 Oct 2026 A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State
Phase 3Recruiting 11 Dec 2029 A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Phase 3Completed 23 Jul 2026 A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity
Phase 2Completed 28 Dec 2021 A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid Arthritis
Phase 2Withdrawn Dec 2021 Safety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Kidney Transplantation From a Deceased Donor
Phase 2Completed 18 Jul 2022 A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant
Phase 2Completed 1 Sep 2022 A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome
Phase 1Completed 21 May 2018 A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid Arthritis
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Dazodalibep

Following is part of Solo: you see every change to Dazodalibep the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in